Federal Register / Vol. 79, No. 210 / Thursday, October 30, 2014 / Notices 64631 

The Section 106 documents listed in 

the above table are also publicly 

available on the NRC Web site at: 

http://www.nrc.gov/info-finder/

materials/uranium/licensed-facilities/

crow-butte/section-106-license-renewaldocs.html. 

Dated at Rockville, Maryland, this 24th day 

of October, 2014. 

For the Nuclear Regulatory Commission. 

Marissa G. Bailey, 

Director, Division of Fuel Cycle Safety, 

Safeguards and Environmental Review, Office 

of Nuclear Material Safety and Safeguards. 

[FR Doc. 2014–25853 Filed 10–29–14; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Meeting Notice 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) will convene a 

teleconference meeting of the Advisory 

Committee on the Medical Uses of 

Isotopes (ACMUI) on December 10, 

2014, to discuss the Committee’s 

comments on NRC’s Advanced Notice of 

Proposed Rulemaking for Title 10 of the 

Code of Federal Regulations for Part 20. 

Meeting information, including a copy 

of the agenda and handouts, will be 

available at http://www.nrc.gov/readingrm/doc-collections/acmui/meetings/

2014.html. The agenda and handouts 

may also be obtained by contacting Ms. 

Sophie Holiday using the information 

below. 

DATE: The teleconference meeting will 

be held on Wednesday, December 10, 

2014, 2:00 p.m. to 4:00 p.m. Eastern 

Daylight Time (EDT). 

Public Participation: Any member of 

the public who wishes to participate in 

the teleconference should contact Ms. 

Holiday using the contact information 

below. 

Contact Information: Sophie Holiday, 

email: sophie.holiday@nrc.gov, 

telephone: (301) 415–7865. 

Conduct of the Meeting 

Dr. Bruce Thomadsen, ACMUI 

Chairman, will preside over the 

meeting. Dr. Thomadsen will conduct 

the meeting in a manner that will 

facilitate the orderly conduct of 

business. The following procedures 

apply to public participation in the 

meeting: 

1. Persons who wish to provide a 

written statement should submit an 

electronic copy to Ms. Holiday at the 

contact information listed above. All 

submittals must be received by 

December 05, 2014, three business days 

prior to the meeting, and must pertain 

to the topic on the agenda for the 

meeting. 

2. Questions and comments from 

members of the public will be permitted 

during the meetings, at the discretion of 

the Chairman. 

3. The draft transcript and meeting 

summary will be available on ACMUI’s 

Web site http://www.nrc.gov/readingrm/doc-collections/acmui/meetings/

2014.html on or about January 23, 2015. 

This meeting will be held in 

accordance with the Atomic Energy Act 

of 1954, as amended (primarily Section 

161a); the Federal Advisory Committee 

Act (5 U.S.C. App); and the 

Commission’s regulations in Title 10, 

U.S. Code of Federal Regulations, Part 7. 

Dated: October 24, 2014 

Andrew L. Bates, 

Advisory Committee Management Officer. 

[FR Doc. 2014–25854 Filed 10–29–14; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Call for Nominations 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Call for Nominations. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is advertising for 

nominations for the position of 

radiation therapy medical physicist on 

the Advisory Committee on the Medical 

Uses of Isotopes (ACMUI). 

DATES: Nominations are due on or 

before January 13, 2015. 

Nomination Process: Submit an 

electronic copy of resume or curriculum 

vitae to Ms. Sophie Holiday, 

Sophie.Holiday@nrc.gov. Please ensure 

that the resume or curriculum vitae 

includes the following information, if 

applicable: Education; certification; 

professional association membership 

and committee membership activities; 

duties and responsibilities in current 

and previous clinical, research, and/or 

academic position(s). 

FOR FURTHER INFORMATION CONTACT: Ms. 

Sophie Holiday, U.S. Nuclear 

Regulatory Commission, Office of 

Nuclear Material Safety and Safeguards; 

(301) 415–7865; Sophie.Holiday@

nrc.gov. 

SUPPLEMENTARY INFORMATION: The 

ACMUI advises NRC on policy and 

technical issues that arise in the 

regulation of the medical use of 

byproduct material. 

Responsibilities include providing 

comments on changes to NRC 

regulations and guidance; evaluating 

certain non-routine uses of byproduct 

material; providing technical assistance 

in licensing, inspection, and 

enforcement cases; and bringing key 

issues to the attention of NRC staff, for 

appropriate action. 

ACMUI members possess the medical 

and technical skills needed to address 

evolving issues. The current 

membership is comprised of the 

following professionals: (a) Nuclear 

medicine physician; (b) nuclear 

cardiologist; (c) two radiation 

oncologists; (d) diagnostic radiologist; 

(e) therapy medical physicist; (f) nuclear 

medicine physicist; (g) nuclear 

pharmacist; (h) health care 

administrator; (i) radiation safety officer; 

(j) patients’ rights advocate; (k) Food 

and Drug Administration representative; 

and (l) Agreement State representative. 

NRC is inviting nominations for the 

therapy medical physicist to the 

ACMUI. The term of the individual 

currently occupying this position will 

end October 15, 2015. Committee 

members currently serve a four-year 

term and may be considered for 

reappointment to an additional term. 

Nominees must be U.S. citizens and 

be able to devote approximately 160 

hours per year to Committee business. 

Members who are not Federal 

employees are compensated for their 

service. In addition, members are 

reimbursed for travel (including perdiem in lieu of subsistence) and are 

reimbursed secretarial and 

correspondence expenses. Full-time 

Federal employees are reimbursed travel 

expenses only. 

Security Background Check: The 

selected nominee will undergo a 

thorough security background check. 

Security paperwork may take the 

nominee several weeks to complete. 

Nominees will also be required to 

complete a financial disclosure 

statement to avoid conflicts of interest. 

Dated at Rockville, Maryland this 24th day 

of October, 2014. 

For the U.S. Nuclear Regulatory 

Commission. 

Andrew L. Bates, 

Advisory Committee Management Officer. 

[FR Doc. 2014–25851 Filed 10–29–14; 8:45 am] 

BILLING CODE 7590–01–P 


tkelley on DSK3SPTVN1PROD with NOTICES